glp 1 agonist crohn's disease glp-1 COMMIT-CD: A Phase 3b trial evaluating the efficacy & safety of Weight Loss Medications & IBD

Made in Italy FAQs

Methods Patient-reported HRQoL data are from a pooled analysis of the pivotal GOLDEN-3 (NCT02347761) and GOLDEN-4 (NCT02347774) studies, and a separate analysis of the long-term GOLDEN-5 study (NCT02276222)

Diabetes Obes Metab 27(2):806815 Simms-Williams N, Treves N, Yin H, Lu S, Yu O, Pradhan R et al (2024) Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population-based cohort study

When you choose high-quality, bioavailable formulas, you are ensuring that your efforts aren't wasted